03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Combipar 100/25/200mg : | |
Type | Medicine Authorised |
Originator | Stalevo 100/25/200mg |
Agent | Pharmaline |
Distributor | Pharmaline |
Laboratory | Tripharma |
Manufacturer | Pharmaline SAL* |
Manufacturing Type | Pharmaline Licensed by Tripharma, Turkey |
Origin | Lebanon |
ATC | N04BA03 |
Combipar 100/25/200mg :
Combipar 100/25/200mg :
Combipar 100/25/200mg :
Combipar 100/25/200mg :
Combipar 100/25/200mg :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Combipar 100/25/200mg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal discomfort | Common |
Abdominal pain | Common |
Abnormal dreams | Common |
Agitation | Uncommon |
Anaemia | Common |
Angina pectoris | Common |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
Anxiety | Common |
Arthralgia (Pain joint) (Joint ache) | Common |
Asthenia | Common |
Binge eating | Not known |
Bradykinesia | Common |
Chest pain | Common |
Chromaturia | Very Common |
Colitis | Uncommon |
Compulsive eating | Not known |
Compulsive shopping | Not known |
Confusional state | Common |
Connective tissue disorder | Very Common |
Constipation | Common |
Decreased appetite | Common |
Dementia | Common |
Depression | Common |
Diarrhoea (Diarrhea) | Very Common |
Dizziness | Common |
Dry mouth (Xerostomia) | Common |
Dyskinesia | Very Common |
Dyspepsia | Common |
Dysphagia | Uncommon |
Dyspnoea (dyspnea) | Common |
Dystonia | Common |
Fall | Common |
Fatigue | Common |
Gait disturbance | Common |
Gastroduodenal haemorrhage | Uncommon |
Hair colour changes | Uncommon |
Hallucination | Common |
Headache | Common |
Heart rate increased | Common |
Hepatitis cholestatic | Not known |
Hyperhidrosis | Common |
Hypersexuality | Not known |
Hypertension | Common |
Insomnia | Common |
Libido increased | Not known |
Liver function test abnormal | Uncommon |
Malaise | Uncommon |
Memory impairment | Common |
Mental impairment | Common |
Muscle spasms | Common |
Musculoskeletal pain | Very Common |
Myalgia | Very Common |
Myocardial infarction | Uncommon |
Myocardial ischaemia | Common |
Nail discolouration | Uncommon |
Nausea | Very Common |
Neuroleptic malignant syndrome | Not known |
Nightmares | Common |
Oedema peripheral | Common |
On and off phenomenon | Common |
Orthostatic hypotension | Common |
Parkinsonism | Common |
Pathological gambling | Not known |
Psychotic disorders | Uncommon |
Rhabdomyolysis | Not known |
Seizures | Not known |
Skin discolouration (Dyschromia) | Uncommon |
Skin rash | Common |
Somnolence | Common |
Sudden onset of sleep | Not known |
Suicidal behaviour | Not known |
Sweat discolouration | Uncommon |
Thrombocytopenia (Thrombopenia) | Uncommon |
Tremor | Common |
Urinary retention | Uncommon |
Urinary tract infection | Common |
Urticaria | Not known |
Vision blurred | Common |
Vomiting | Common |
Weight decreased (Weight loss) | Common |
Withdrawal syndrome | Not known |
Combipar 100/25/200mg :
Combipar 100/25/200mg :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Combipar 100/25/200mg MoH 9123 :
Form | Tablet, Film-Coated |
Package Size | Box of 50 |
Strength | 100mg/25mg/200mg |
Public Price | 1167070.28 L.L. |
Stratum | A2 |
NSSF | ✔ |
Quarantine | ✘ |
Reg. Number | 101716/1 |
Submission date | 01/01/2016 |
Registration Year | 2017 |
Barcode | 5281019903642 |
Price Comparison
You have to register to view this info
You have to register to view this info
You have to register to view this info
Drop File